The revenue stands at ₹4,336.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.00 per cent from ₹4,516.60 crore. This corresponds to a year-on-year *(YoY) growth of 10.00 per cent.
Operating Profit stands at ₹833.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.30 per cent from ₹939.90 crore. This corresponds to a year-on-year *(YoY) growth of 11.32 per cent.
PBDT stands at ₹675.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.29 per cent from ₹760.90 crore. This corresponds to a year-on-year *(YoY) growth of 22.30 per cent.
Profit Before Tax stands at ₹127.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 48.44 per cent from ₹247.50 crore. This corresponds to a year-on-year *(YoY) growth of 31.68 per cent.
Net Profit stands at ₹136.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.12 per cent from ₹198.60 crore. This represents a 53.36 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Biocon | -0.94% | -1.94% | -8.49% | -5.47% | 0.95% | 7.91% |
| Dr Reddy's Labs | -0.78% | -1.38% | -1.07% | -9.75% | -10.99% | -11.48% |
| Aurobindo Pharma | 0.28% | 0.10% | 0.73% | 14.65% | 32.96% | 58.80% |
| Glenmark Pharma. | 1.44% | 0.42% | 7.23% | 11.54% | 16.30% | 16.34% |
| Alkem Lab | -0.23% | -0.58% | -6.43% | -3.22% | -5.13% | -2.84% |
| Abbott India | -1.04% | -0.86% | -6.35% | -1.32% | -5.00% | -15.80% |
| Anthem Bioscienc | 0.01% | 0.02% | 9.45% | 20.00% | 41.52% | 14.06% |
Chairperson : Kiran Mazumdar Shaw
Non-Exec & Non-Independent Dir : Ravi Mazumdar
Non-Exec & Non-Independent Dir : Eric Vivek Mazumdar
Lead Independent Director : Naina Lal Kidwai
Independent Non Exe. Director : Rekha Mehrotra Menon
Independent Non Exe. Director : NICHOLAS ROBERT HAGGAR
Independent Non Exe. Director : Atul Dhawan
Managing Director & CEO : Shreehas Pradeep Tambe
Company Sec. & Compli. Officer : RAJESH UMAKANT SHANOY